comparemela.com

Latest Breaking News On - Dosing regimens - Page 2 : comparemela.com

Stoke Therapeutics to Present Data from the Company s Dravet Syndrome Clinical Program at the American Epilepsy Society 2023 Annual Meeting -November 21, 2023 at 08:05 am EST

Anti-Amyloid Monoclonal Antibody Drugs Continue to Show Promise Treating Alzheimer Disease

New anti-amyloid monoclonal antibody drugs for Alzheimer disease have produced encouraging results in targeting the accumulation of amyloid beta plaques; however, questions remain regarding the risk-benefit profile and cost implications.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.